ClinicalTrials.Veeva

Menu

Survey on the Clinical Use of Recombinant Human Erythropoietin in VLBW and ELBW Infants (NSEPO)

S

Southern University of Science and Technology

Status

Unknown

Conditions

Erythropoietin; Infant; Surveys and Questionnaires

Treatments

Other: not use of any intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05372211
Shenzhen NICUs

Details and patient eligibility

About

Recombinant human erythropoietin (rhEPO) has been shown to effectively and safely prevent the anemia of prematurity and to reduce the transfusion need in very low birth weight (VLBW) and extremly low birth weight (ELBW) infants and has been licensed for this indication in Europe in 1997. The objective of the study was to obtain information on the use or nonuse of rhEPO in neonatal units in China.

Full description

The survey was developed by a team of neonatologists at Shenzhen People's hospital . The survey consisted of 26 questions covering three areas: the characteristics of the survey respondents, the use of rhEPO in VLBW and ELBW infants , and other related questions. The questionnaire was presented in the Questionnaire Star format (https://www.wjx.cn/, Hangzhou Oway Medical Technology,Changsha, China). we plan to conduct a cross-sectional survey through the Neonatal Professional Committee of the Chinese Medical Doctor Association WeChat platform. The questionnaire is going to be distributed to nearly 500 representative neonatologists and pediatricians from general hospitals, maternity and infant hospitals, and children's hospitals across the country. Furthermore, this study was approved by the ethics committee of the Shenzhen People's Hospital.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

neonatologists and pediatricians from general hospitals, maternity and infant hospitals, and children's hospitals across China

Exclusion criteria

neonatologists and pediatricians from same hospitals

Trial design

500 participants in 3 patient groups

General hospital group
Description:
Questionnaires collected from general hospitals in China
Treatment:
Other: not use of any intervention
Maternity and infant hospital group
Description:
Questionnaires collected from Maternity and infant hospitals in China
Treatment:
Other: not use of any intervention
Children's hospital
Description:
Questionnaires collected from Children's hospitals in China
Treatment:
Other: not use of any intervention

Trial contacts and locations

0

Loading...

Central trial contact

Zhangbin Yu, Doctor; Xudong Yan, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems